| Stage | SYY | % of rev | CSCO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $21.7B | 100.00% | $17.3B | 100.00% | SYY ×1.26 |
| Gross profit | $4.1B | 18.63% | $11.1B | 64.13% | CSCO +45.5pp |
| Operating income | $717M | 3.30% | $4.3B | 24.72% | CSCO +21.4pp |
| Pre-tax income | $687M | 3.16% | $4.9B | 28.59% | CSCO +25.4pp |
| Net income | $526M | 2.42% | $3.9B | 22.37% | CSCO +19.9pp |
| Stage | SYY | CSCO | Gap · A − B |
|---|---|---|---|
| Revenue | $21.7B100.00% | $17.3B100.00% | SYY ×1.26 |
| Gross profit | 18.63%$4.1B | 64.13%$11.1B | CSCO +45.5pp |
| Operating income | 3.30%$717M | 24.72%$4.3B | CSCO +21.4pp |
| Pre-tax income | 3.16%$687M | 28.59%$4.9B | CSCO +25.4pp |
| Net income | 2.42%$526M | 22.37%$3.9B | CSCO +19.9pp |
No shared counterparties.